Sports Medicine Physicians & Surgeons
Vascular Medicine Physicians & Surgeons
Alabama, Alaska, Arizona, Arkansas, California....
New Additions and Updates
Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device
ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. ABSORB IV is designed to enroll approximately 3,000 people with coronary artery disease ...
Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care
Center for Vascular Medicine now offers genetic testing as a diagnostic tool in its approach to treating patients with vascular conditions including peripheral artery disease (PAD). (PRWeb September 15, 2014) Read the full story at http://www.prweb.com/releases/peripheral-artery-disease/maryland/prweb12166680.htm
First European Patients Enrolled in QT Vascular's ENDURE Trial
SINGAPORE, Sept. 15, 2014 /PRNewswire/ -- Catalist-listed QT Vascular Ltd. ("QT Vascular" or together with its subsidiaries, "the Group"), a developer and manufacturer of minimally invasive medical devices for the treatment of vascular diseases, is pleased to announce that the Group has enrolled the first European patients in the ENDURE Trial in Germany. ENDURE is a single-arm core-lab ...
10 warning signs of Alzheimer's
More than 5 million Americans are living with Alzheimer's today, with another person developing the disease every 68 seconds. By 2050, the number of people living with Alzheimer's disease is expected to triple.
Researchers define spontaneous retinal neovascular mouse model
Researchers have characterized a novel mutant mouse model, termed neoretinal vascularization 2, which develops abnormal neovessels from retinal vascular plexus. Their hope is this new model will help them understand AMD and develop new treatments for the disease.
Abbott Labs Presents Positive One-Year Data on Absorb
Abbott Laboratories (ABT) announced positive one-year results from the randomized, controlled trial ABSORB II, on its drug-eluting coronary bioresorbable vascular scaffold (BVS) Absorb.
Covidien Acquires Reverse Medical, Shares Decline
The acquisition of Reverse Medical is expected to complement Covidien plc's (COV) existing portfolio of vascular technologies, lending it a competitive edge in the worldwide vascular embolization market....
LeMaitre Vascular Opens Office in Shanghai, China
BURLINGTON, Mass. -- LeMaitre Vascular, Inc. , a provider of peripheral vascular devices and implants, announced today that it has opened an office in Shanghai, China. To prepare for this initiative, the ...
Midtown Dentistry Warns Patients Not to Ignore Bleeding Gums
Midtown Dentistry in Houston, Texas, is currently trying to raise patients’ awareness of the connections between gum disease and general health. Numerous clinical studies have shown gum health can affect your general health, and vice versa, so it is vitally important not to miss regular checkups. (PRWeb August 24, 2014) Read the full story at http://www.prweb.com/releases/2014/08/prweb12113885 ...
High rate of heart disease, mental health problems in ACT need addressing: report
ACT residents have the highest proportion of heart disease, stroke and vascular disease in the nation, according to a new report aiming to highlight problem areas for the territory's health system.